Teleflex Incorporated (NYSE:TFX) Receives $252.50 Consensus Target Price from Brokerages

Shares of Teleflex Incorporated (NYSE:TFX) have earned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $252.50.

A number of analysts have recently issued reports on the company. Truist Financial reduced their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada reduced their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Mizuho reduced their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th.

Institutional Trading of Teleflex

Several large investors have recently added to or reduced their stakes in TFX. Janus Henderson Group PLC boosted its holdings in Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after purchasing an additional 147,147 shares in the last quarter. State Street Corp boosted its stake in shares of Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after acquiring an additional 5,746 shares during the last quarter. Cooke & Bieler LP increased its holdings in shares of Teleflex by 23.3% during the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after acquiring an additional 172,335 shares during the last quarter. Finally, TD Asset Management Inc raised its stake in shares of Teleflex by 12.0% in the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock valued at $95,928,000 after acquiring an additional 48,832 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Trading Down 0.3 %

Shares of TFX opened at $179.51 on Wednesday. The business’s 50-day moving average price is $196.65 and its 200 day moving average price is $218.33. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $8.34 billion, a P/E ratio of 35.69, a P/E/G ratio of 1.84 and a beta of 1.16. Teleflex has a 1-year low of $171.69 and a 1-year high of $256.85.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the firm posted $3.64 earnings per share. Analysts expect that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex’s payout ratio is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.